We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find a property's energy certificate including an energy performance certificate (EPC), display energy certificate (DEC) or air conditioning inspection certificate.…
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
Projects granted during 2014 that have a primary purpose of basic research into the musculoskeletal system.
Employment Tribunal decision.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
Upper Tribunal Tax and Chancery decision of Mr Justice Newey on 24 October 2011.
The most recent scientific research on exposure to electric and magnetic fields.
The statutory programmes of study and attainment targets for science at key stages 1 to 4.
Looking into how some factors that can influence the performance of people on board can lead to more accidents as well as how to mitigate or control these factors.
Dance programme to improve the health and wellbeing of community-dwelling older adults.
Information for members of the public who have been affected by the detection of influenza A(H1N2)v in humans for the first time in the UK.
EAMS scientific opinion issued to Amicus Therapeutics UK Limited for cipaglucosidase alfa with miglustat in the treatment of adult patients with late-onset Pompe disease previously treated with alglucosidase alfa.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).